Brand value is built on extensive scientific research and supporting literatures, sufficient safety data, and reliable quality assurances.
PostbiotiX® CB-102 | Immune and Respiratory Relief Postbiotic
Introduction
PostbiotiX® CB-102, a postbiotic derived from Lactobacillus plantarum found in narezushi, was developed in collaboration with one of leading university in Taiwan. This innovative postbiotics is designed to mitigate the adverse effects of PM 2.5 by supporting immune function, alleviating allergy symptoms and reducing lung damage.
The PostbiotiX® series is further processed using a patented ProbioAid® anti-aggregation technology, enhancing the bioavailability and ensuring optimal dispersion. This innovation boosts probiotic growth by 500% and enhances immune protection by 50%.
Function
- Restore immunity by balancing Th1/Th2 cell.
- Alleviate allergy induced by PM2.5 by lowering IgE level.
- Reduce inflammation in lung tissue caused by PM2.5.
Advantages
- Heat and acid stable postbiotics with advanced bioavailability.
- 2 Scientific Studies, 12 Patents Received.
Specification
| Origin | Taiwan |
| Application | Supplements, Liquid/Jelly sachet, General foods, Beverages |
| Dosage | 20 mg/day |